NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Brains Bioceutical Corp

Brains Bioceutical Corp

Private
VancouverHealthcare & Life Scienceshttps://brainsbioceutical.com/

Last Round

VC Round

Nov 8, 2021

Company Overview

Brains Bioceutical Corp is a pharmaceutical and biotechnology company that manufactures and supplies natural, EU-GMP certified cannabinoid active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceutical, and veterinary applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

cannabinoid APIactive pharmaceutical ingredientsAPIEU-GMP certifiedcannabidiolCBDpharmaceutical manufacturingdrug developmentnutraceutical ingredientsTHC APIclinical trial supportcannabis pharmaveterinary healthdrug master fileDMF

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Brains Bioceutical Corp Comparables

Compare Brains Bioceutical Corp with similar companies based on industry and business-model similarity.

Brains Bioceutical Corp comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Linneo Health
83%
Averix Bio, LLC
83%
CBDepot
83%

Brains Bioceutical Corp Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 8, 2021
VC RoundJun 16, 2021
VC RoundDec 19, 2019

Key People

Founding team and executive leadership

Ricky Brar

CEO & Chairman

Executive Team

Jasvinder Kalsi

Chief Financial Officer

Executive Team

Dean Billington

Chief Operating Officer

Executive Team

Brains Bioceutical Corp Investors

Notable investors and investment history

Brains Bioceutical Corp investors
InvestorRounds
DSM VenturingVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 13, 2024

    Monthly visitors grew 31% MoM, reaching 1.7K.

  • Dec 19, 2019

    $30M round raised from investors.

Brains Bioceutical Corp Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Brains Bioceutical Corp Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Brains Bioceutical Corp's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Employee Range21
Year FoundedN/A
Last FundingNov 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.